New COVID-19 booster shots put to the test in small human trial

NCT ID NCT07605520

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen May 30, 2026 · Last updated Jun 18, 2026 · Updated 3 times

Summary

This study tests two experimental COVID-19 booster vaccines alongside two already-approved ones in 48 healthy adults aged 18 to 65. Participants receive one injection and are monitored for side effects and antibody levels over 48 weeks. The goal is to see if the new vaccines are safe and produce a strong immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CIC 1417 - Hôpital Cochin
RECRUITING

Paris, France

Contact Email: •••••@•••••
Centre Hospitalier Universitaire Vaudois (CHUV)
RECRUITING

Lausanne, Switzerland

Contact Email: •••••@•••••
Hôpital Henri Mondor
RECRUITING

Créteil, France

Contact Email: •••••@•••••

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULTS